Synthetic thymosin alpha 1 (Tα1) peptide has been approved by the FDA for treatment of malignant melanoma, Hepatitis B and C, and influenza. It is indicated as adjuvant therapy for support of immune systems suppressed by chemotherapy.
Thymosin Beta 4 has been found to support protection and regeneration of damaged tissues, so it is primarily recommended to assist in the healing of acute injury, post-surgically, and for older athletes.
GHK-Cu/Argirelin/Leuphasyl is a peptide serum used topically to help reduce facial wrinkles and lines, improve skin density, firmness, and elasticity; reduce free radical damage to the skin; and reduce sun-spots and skin hyperpigmentation. GHK-Cu alone also helps with wound healing and may be used topically or as an injected peptide for this purpose.